FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2553326092> ?p ?o ?g. }

• W2553326092 abstract "In stable adult cystic fibrosis (CF) patients, we assessed the role of baseline high sensitivity C-reactive protein (hs-CRP) on CF clinical variables and frequency of intravenous (IV) treated pulmonary exacerbations (PExs) 1-year post-baseline.We recruited 51 clinically stable CF patients from our Adult CF Center. We incorporated collected parameters into Matouk CF clinical score and CF questionnaire-revised quality of life score (QOL). We used the clinical minus complications subscores as a clinical disease activity score (CDAS). We dichotomized our patients according to the cohort median baseline hs-CRP of 5.2 mg/L.Patients in the high hs-CRP group (≥ 5.2 mg/L) demonstrated worse CDAS (r=0.67, p=0.0001) and QOL scores (r=0.57, p=0.0017) at a given FEV1% predicted. In both hs-CRP groups, prior-year IV-treated PExs and baseline CDASs were significant predictors of future IV-treated PExs. Interestingly, the association between baseline CDAS and future PExs frequency was more robust in the high compared to the low hs-CRP group (r=-0.88, p<0.0001, r=-0.48, p=0.017, respectively) with a steeper regression slope (p=0.001). In addition, a significant interaction was demonstrated between elevated baseline hs-CRP levels and CDASs for the prediction of increased risk of future PExs (p=0.02). This interaction provided an additional indicator of clinical disease activity and added another dimension to the prior year PExs frequency phenotype to identify patients at increased risk for future PExs.Stable CF patients with elevated baseline hs-CRP (≥ 5.2 mg/L) demonstrated worse clinical disease activity and QOL scores at a given level of disease severity (FEV1% predicted). Elevated baseline hs-CRP values combined with clinical disease activity scores are associated with increased risk for future IV-treated PExs even in those with mild clinical disease activity scores." @default.
• W2553326092 created "2016-11-30" @default.
• W2553326092 creator A5005067201 @default.
• W2553326092 creator A5023340495 @default.
• W2553326092 creator A5032795844 @default.
• W2553326092 creator A5053473599 @default.
• W2553326092 creator A5067663053 @default.
• W2553326092 creator A5071434659 @default.
• W2553326092 creator A5077086518 @default.
• W2553326092 creator A5079250343 @default.
• W2553326092 creator A5081634444 @default.
• W2553326092 creator A5086057099 @default.
• W2553326092 creator A5088995714 @default.
• W2553326092 date "2016-01-01" @default.
• W2553326092 modified "2023-10-16" @default.
• W2553326092 title "C-Reactive Protein in Stable Cystic Fibrosis: An Additional Indicator of Clinical Disease Activity and Risk of Future Pulmonary Exacerbations" @default.
• W2553326092 cites W1715680901 @default.
• W2553326092 cites W1741300860 @default.
• W2553326092 cites W1771472508 @default.
• W2553326092 cites W1975572445 @default.
• W2553326092 cites W1983553197 @default.
• W2553326092 cites W1991265445 @default.
• W2553326092 cites W2010151747 @default.
• W2553326092 cites W2024886564 @default.
• W2553326092 cites W2047779780 @default.
• W2553326092 cites W2054324432 @default.
• W2553326092 cites W2068259100 @default.
• W2553326092 cites W2069875525 @default.
• W2553326092 cites W2076243728 @default.
• W2553326092 cites W2079107579 @default.
• W2553326092 cites W2095222752 @default.
• W2553326092 cites W2098294550 @default.
• W2553326092 cites W2109247335 @default.
• W2553326092 cites W2112770978 @default.
• W2553326092 cites W2116295439 @default.
• W2553326092 cites W2119972555 @default.
• W2553326092 cites W2123178771 @default.
• W2553326092 cites W2126746088 @default.
• W2553326092 cites W2132861283 @default.
• W2553326092 cites W2133497705 @default.
• W2553326092 cites W2137680215 @default.
• W2553326092 cites W2144947606 @default.
• W2553326092 cites W2146292644 @default.
• W2553326092 cites W2158389196 @default.
• W2553326092 cites W2161450374 @default.
• W2553326092 cites W2168706325 @default.
• W2553326092 cites W2190406315 @default.
• W2553326092 cites W2301131921 @default.
• W2553326092 cites W4244598283 @default.
• W2553326092 cites W4254959762 @default.
• W2553326092 doi "https://doi.org/10.4172/2161-105x.1000375" @default.
• W2553326092 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5218840" @default.
• W2553326092 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28066689" @default.
• W2553326092 hasPublicationYear "2016" @default.
• W2553326092 type Work @default.
• W2553326092 sameAs 2553326092 @default.
• W2553326092 citedByCount "17" @default.
• W2553326092 countsByYear W25533260922017 @default.
• W2553326092 countsByYear W25533260922018 @default.
• W2553326092 countsByYear W25533260922019 @default.
• W2553326092 countsByYear W25533260922020 @default.
• W2553326092 countsByYear W25533260922021 @default.
• W2553326092 countsByYear W25533260922022 @default.
• W2553326092 countsByYear W25533260922023 @default.
• W2553326092 crossrefType "journal-article" @default.
• W2553326092 hasAuthorship W2553326092A5005067201 @default.
• W2553326092 hasAuthorship W2553326092A5023340495 @default.
• W2553326092 hasAuthorship W2553326092A5032795844 @default.
• W2553326092 hasAuthorship W2553326092A5053473599 @default.
• W2553326092 hasAuthorship W2553326092A5067663053 @default.
• W2553326092 hasAuthorship W2553326092A5071434659 @default.
• W2553326092 hasAuthorship W2553326092A5077086518 @default.
• W2553326092 hasAuthorship W2553326092A5079250343 @default.
• W2553326092 hasAuthorship W2553326092A5081634444 @default.
• W2553326092 hasAuthorship W2553326092A5086057099 @default.
• W2553326092 hasAuthorship W2553326092A5088995714 @default.
• W2553326092 hasBestOaLocation W25533260921 @default.
• W2553326092 hasConcept C126322002 @default.
• W2553326092 hasConcept C159110408 @default.
• W2553326092 hasConcept C2776914184 @default.
• W2553326092 hasConcept C2776938444 @default.
• W2553326092 hasConcept C2779951463 @default.
• W2553326092 hasConcept C2781195455 @default.
• W2553326092 hasConcept C71924100 @default.
• W2553326092 hasConcept C72563966 @default.
• W2553326092 hasConcept C90924648 @default.
• W2553326092 hasConceptScore W2553326092C126322002 @default.
• W2553326092 hasConceptScore W2553326092C159110408 @default.
• W2553326092 hasConceptScore W2553326092C2776914184 @default.
• W2553326092 hasConceptScore W2553326092C2776938444 @default.
• W2553326092 hasConceptScore W2553326092C2779951463 @default.
• W2553326092 hasConceptScore W2553326092C2781195455 @default.
• W2553326092 hasConceptScore W2553326092C71924100 @default.
• W2553326092 hasConceptScore W2553326092C72563966 @default.
• W2553326092 hasConceptScore W2553326092C90924648 @default.
• W2553326092 hasIssue "5" @default.
• W2553326092 hasLocation W25533260921 @default.
• W2553326092 hasLocation W25533260922 @default.
• W2553326092 hasLocation W25533260923 @default.
• W2553326092 hasLocation W25533260924 @default.

• next